Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CXXC finger protein 1 (CXXC1/CFP1) is a DNA-binding protein featuring a CXXC-type zinc finger domain and a PHD finger domain. CXXC1 binds specifically to unmethylated CpG motifs—especially CpG islands within active promoters—via its CXXC domain, and functions as a targeting subunit for the SETD1/COMPASS histone H3K4 methyltransferase complex[2][4][6]. Through this activity, CXXC1 ensures proper chromatin state, regulating gene expression, and maintaining the epigenetic landscape necessary for cell differentiation and development[1][2][4][6]. In immune cells, CXXC1 is a critical cofactor for FOXP3, orchestrating the regulatory T cell transcriptional program; its loss disrupts immune homeostasis and can induce severe autoimmune disease in model organisms[5]. Structure-function studies reveal CXXC1 contains redundant domains crucial for cytosine methylation and histone modification, and knockout models display broad defects across growth, differentiation, and DNA repair pathways[1][3][4]. CXXC1 has not been identified as a direct drug target, but its role in epigenetic regulation makes it a potential locus for future therapeutic development, particularly in oncology, immunology, and developmental disorder research.
Not directly targeted by known drugs; theoretical mechanism would involve: - Inhibition of CpG binding - Modulation of SETD1/COMPASS complex activity - Alteration of histone/K4 methylation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CXXC finger protein 1 (CXXC1 (CFP1)).